Further functional radiobiologic assays and analysis of JAK2/STAT3/CCND2 in a retrospective cohort of patients who were treated with RT may lead to the development of novel predictive biomarkers of radiation response in CRC. This evidence concerns the gene JAK2 and colorectal carcinoma.